ABT-269

N/A

Report date: 2023/05/22 10:16:30

Base Information

Drug NameABT-269

Drug Alias NameN/A

ClassificationSmall molecules

Mechanisms of ActionMotilin stimulants

TargetsMotilin

Therapy Area/IndicationsGastrointestinal Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAbbott Laboratories

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAbbott Laboratories

Active IndicationsN/A

Inactive IndicationsGastrointestinal Diseases

Other Information

ATC CodeN/A

Related LinksN/A